Show simple item record

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

dc.contributor.authorChanan-Khan, Aen_US
dc.contributor.authorEgyed, Men_US
dc.contributor.authorRobak, Ten_US
dc.contributor.authorMartinelli de Oliveira, FAen_US
dc.contributor.authorEcheveste, MAen_US
dc.contributor.authorDolan, Sen_US
dc.contributor.authorDesjardins, Pen_US
dc.contributor.authorBlonski, JZen_US
dc.contributor.authorMei, Jen_US
dc.contributor.authorGolany, Nen_US
dc.contributor.authorZhang, Jen_US
dc.contributor.authorGribben, JGen_US
dc.date.accessioned2018-03-14T11:41:14Z
dc.date.available2017-01-31en_US
dc.date.issued2017-05en_US
dc.date.submitted2018-03-14T11:19:15.557Z
dc.identifier.issn0887-6924en_US
dc.identifier.other10.1038/leu.2017.47
dc.identifier.urihttps://www.nature.com/articles/leu201747.pdf
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/35464
dc.description.sponsorshipThis study was funded by Celgene Corporation.en_US
dc.format.extent1240 - 1243en_US
dc.language.isoenen_US
dc.relation.ispartofLEUKEMIAen_US
dc.rightsCreative Commons Attribution License
dc.titleRandomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)en_US
dc.typeArticle
dc.rights.holder2017 The Authors.
dc.identifier.doi10.1038/leu.2017.47en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000400464800027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue5en_US
pubs.notesNo embargoen_US
pubs.publication-statusPublisheden_US
pubs.volume31en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record